A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

ORTHO Optix Reader Receives CE Mark and Available in Countries That Accept the CE Mark

November 30, 2020

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the CE Mark availability of the semi-automated ORTHO Optix™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected of an automated platform.

Ortho Clinical Diagnostics notes the ORTHO Optix Reader’s high-resolution camera captures color, grayscale, front and back images of each test without operator intervention, which provides objective data for automated results interpretation and eliminates the subjectivity and discrepancies of multiple operators reviewing images by eye.

When paired with the ORTHO™ Workstation, the ORTHO Optix Reader provides a complete semi-automated testing platform for transfusion labs with low- to mid-volume throughput. Because the ORTHO Optix Reader has been shown to deliver 99.9% concordance1 with the fully automated ORTHO VISION® Analyzer, it also offers larger volume labs and health care networks a way to back-up or scale up their operations without having to invest in an additional full-automation analyzer. The concordant and high-resolution images of the ORTHO Optix Reader also help to support the technologist during remote review of results from across the laboratory.

“The ORTHO Optix Reader allows transfusion medicine labs with smaller testing volumes the same high-quality, consistent results demonstrated from the award-winning, fully automated ORTHO VISION Analyzer,” said Bob Stowers, Ortho’s head of transfusion medicine product portfolio. “With the ORTHO Optix Reader now included in Ortho’s comprehensive portfolio of automated and semi-automated solutions, labs of all sizes can customize Ortho’s solutions to optimize their resources without compromising quality and accuracy.”

The ORTHO Optix Reader leverages the same proven ORTHO BioVue® System Column Agglutination Technology as the ORTHO VISION Analyzer and a comprehensive testing menu including antibody panels, selected cells and dilution series.

When connected to the customer’s LIS, column grades and images can be automatically sent for long-term retention of result interpretations, therefore reducing and/or eliminating the need for manual documentation of results. The system audit log and reporting module enhances traceability to help labs stay compliant with accreditations and regulations. It also includes QC management capabilities along with assay and reagent tracking to help standardize lab practices.

The ORTHO Optix Reader is supported by Ortho Care™, Ortho’s award-winning, holistic service and support solution, and is now available in countries that accept CE Mark.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy